|
ATE485837T1
(de)
*
|
2000-08-03 |
2010-11-15 |
Antares Pharma Ipl Ag |
Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
|
PE20020578A1
(es)
|
2000-10-10 |
2002-08-14 |
Upjohn Co |
Una composicion de antibiotico topico para el tratamiento de infecciones oculares
|
|
US6566556B2
(en)
*
|
2000-12-19 |
2003-05-20 |
Nippon Shokubai Co., Ltd. |
Method for production of alkanolamine and apparatus therefor
|
|
MXPA03011793A
(es)
*
|
2001-06-29 |
2004-04-02 |
Maxygen Holdings Ltd |
Formulaciones de interferon.
|
|
US7141540B2
(en)
*
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
|
PT1456377T
(pt)
*
|
2001-12-20 |
2019-09-10 |
Merck Sharp & Dohme |
Composições de syn3 e processos
|
|
MXPA04008171A
(es)
*
|
2002-02-22 |
2004-11-26 |
Pharmacia Corp |
Formulacion oftalmica con sistema de goma.
|
|
BR0307898A
(pt)
*
|
2002-02-22 |
2004-12-07 |
Pharmacia Corp |
Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
|
|
ATE534373T1
(de)
|
2003-10-10 |
2011-12-15 |
Antares Pharma Ipl Ag |
Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
|
|
US8129346B2
(en)
|
2004-04-15 |
2012-03-06 |
Onyx Therapeutics, Inc. |
Compounds for enzyme inhibition
|
|
US8198270B2
(en)
*
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
|
EP2030981B1
(en)
*
|
2004-05-10 |
2014-07-09 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
|
PT2260835E
(pt)
*
|
2004-12-07 |
2013-05-28 |
Onyx Therapeutics Inc |
Composição para inibição do proteassoma
|
|
US8067399B2
(en)
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
|
MY171061A
(en)
*
|
2005-11-09 |
2019-09-24 |
Onyx Therapeutics Inc |
Compounds for enzyme inhibition
|
|
US20070111965A1
(en)
*
|
2005-11-15 |
2007-05-17 |
Kipp James E |
Compositions comprising lipoxygenase inhibitors and cyclodextrin
|
|
US20070135586A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Shreyas Chakravarti |
Polyamide blend compositions formed article and process thereof
|
|
CN101426475A
(zh)
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
|
CA2657213C
(en)
|
2006-06-19 |
2017-01-03 |
Proteolix, Inc. |
Peptide epoxyketones for proteasome inhibition
|
|
US20090239942A1
(en)
*
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
|
EP2061458B1
(en)
*
|
2006-09-15 |
2014-12-10 |
Regents of the University of Minnesota |
Topiramate compositions and methods for their use
|
|
JP5681485B2
(ja)
|
2007-04-27 |
2015-03-11 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
クロピドグレルおよびスルホアルキルエーテルシクロデキストリンを含有する製剤ならびに使用方法
|
|
US20090082400A1
(en)
*
|
2007-07-31 |
2009-03-26 |
Ving Lee |
Soluble pyrone analogs methods and compositions
|
|
KR20170125413A
(ko)
|
2007-10-04 |
2017-11-14 |
오닉스 세라퓨틱스, 인크. |
결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성
|
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
|
CA2762321A1
(en)
*
|
2008-05-19 |
2009-11-26 |
Texcontor Etablissement |
Fosphenytoin composition
|
|
EP3090737A1
(en)
|
2008-10-21 |
2016-11-09 |
Onyx Therapeutics, Inc. |
Combination therapy with peptide epoxyketones
|
|
US10463677B2
(en)
|
2008-11-07 |
2019-11-05 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
|
TWI504598B
(zh)
|
2009-03-20 |
2015-10-21 |
Onyx Therapeutics Inc |
結晶性三肽環氧酮蛋白酶抑制劑
|
|
CA2761455C
(en)
|
2009-05-13 |
2018-06-12 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
|
PL2434886T3
(pl)
|
2009-05-29 |
2020-05-18 |
Cydex Pharmaceuticals, Inc. |
Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania
|
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
|
US8431576B2
(en)
|
2009-06-25 |
2013-04-30 |
Alkermes Pharma Ireland Limited |
Heterocyclic compounds for the treatment of neurological and psychological disorders
|
|
CA2937222C
(en)
*
|
2009-06-25 |
2019-06-04 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds
|
|
US8853147B2
(en)
|
2009-11-13 |
2014-10-07 |
Onyx Therapeutics, Inc. |
Use of peptide epoxyketones for metastasis suppression
|
|
EP2542238B1
(en)
|
2010-03-01 |
2015-08-12 |
Onyx Therapeutics, Inc. |
Compounds for immunoproteasome inhibition
|
|
NZ602872A
(en)
|
2010-04-07 |
2014-05-30 |
Onyx Therapeutics Inc |
Crystalline peptide epoxyketone immunoproteasome inhibitor
|
|
ES2691671T3
(es)
|
2010-06-24 |
2018-11-28 |
Alkermes Pharma Ireland Limited |
Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
|
|
DE102011011028A1
(de)
*
|
2011-02-11 |
2012-08-16 |
Ditter Plastic Gmbh + Co. Kg |
Frontplatte mit darin eingespritztem Lichtleiter
|
|
HUE065359T2
(hu)
|
2011-03-18 |
2024-05-28 |
Alkermes Pharma Ireland Ltd |
Szorbitán-észtereket tartalmazó gyógyászati készítmények
|
|
DK2758052T3
(en)
|
2011-09-18 |
2018-05-28 |
Euro Celtique Sa |
Pharmaceutical composition comprising an HDAC inhibitor and a cyclopolysaccharide
|
|
JP5952912B2
(ja)
|
2011-12-15 |
2016-07-13 |
アルカーメス ファーマ アイルランド リミテッド |
二級アミン化合物のプロドラッグ
|
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
|
WO2013123254A1
(en)
|
2012-02-15 |
2013-08-22 |
Cydex Pharmaceuticals, Inc. |
Manufacturing process for cyclodextrin derivatives
|
|
RU2615385C2
(ru)
|
2012-02-28 |
2017-04-04 |
Сидекс Фармасьютикалс, Инк. |
Композиции алкилированного циклодекстрина и способы их получения и применения
|
|
ES2950418T3
(es)
|
2012-03-19 |
2023-10-09 |
Alkermes Pharma Ireland Ltd |
Composiciones farmacéuticas que comprenden alcohol bencílico
|
|
JP6219918B2
(ja)
|
2012-03-19 |
2017-10-25 |
アルカームス ファーマ アイルランド リミテッド |
グリセロールエステルを含む医薬組成物
|
|
ES2765036T3
(es)
|
2012-03-19 |
2020-06-05 |
Alkermes Pharma Ireland Ltd |
Composiciones farmacéuticas que comprenden esteres de ácidos grasos
|
|
US20140105921A1
(en)
|
2012-07-09 |
2014-04-17 |
Onyx Therapeutics, Inc. |
Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
|
|
EP2897592B1
(en)
|
2012-09-19 |
2020-02-19 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions having improved storage stability
|
|
KR102112119B1
(ko)
|
2012-10-22 |
2020-05-19 |
사이덱스 파마슈티칼스, 인크. |
알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법
|
|
BR112016021535A8
(pt)
|
2014-03-20 |
2021-07-20 |
Alkermes Pharma Ireland Ltd |
kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso
|
|
GB201409485D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409488D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
PT3183295T
(pt)
|
2014-08-22 |
2023-11-03 |
Cydex Pharmaceuticals Inc |
Composições de ciclodextrina alquilada fracionada e processos para preparação e utilização das mesmas
|
|
GB201609222D0
(en)
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|
|
AU2016426574B2
(en)
|
2016-10-11 |
2023-07-13 |
Euro-Celtique S.A. |
Hodgkin lymphoma therapy
|
|
GB201709406D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro-Cletique S A |
Compounds for treating TNBC
|
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
|
GB201709402D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating t-pll
|
|
GB201709405D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating ovarian cancer
|
|
EP3761983A1
(en)
|
2018-03-05 |
2021-01-13 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
|
KR20210105380A
(ko)
|
2018-12-18 |
2021-08-26 |
먼디파머 인터내셔널 코포레이션 리미티드 |
다발성 골수종을 치료하기 위한 화합물
|
|
US11819503B2
(en)
|
2019-04-23 |
2023-11-21 |
F2G Ltd |
Method of treating coccidioides infection
|
|
CN110279664B
(zh)
*
|
2019-07-30 |
2021-09-03 |
四川农业大学 |
一种氟苯尼考包合物冻干粉针剂及其制备方法
|
|
US20230000997A1
(en)
|
2019-08-06 |
2023-01-05 |
L.E.A.F. Holdings Group Llc |
Processes of preparing polyglutamated antifolates and uses of their compositions
|
|
JP2023551145A
(ja)
|
2020-11-18 |
2023-12-07 |
ベクソン バイオメディカル，インク． |
医薬化合物の錯化剤塩製剤
|
|
AU2020480182B2
(en)
|
2020-12-04 |
2025-02-27 |
Sichuan Credit Pharmaceutical Co., Ltd |
Fosphenytoin sodium solid composition, lyophilization method, and use of fosphenytoin sodium solid composition
|
|
CN118161457A
(zh)
*
|
2020-12-04 |
2024-06-11 |
四川科瑞德制药股份有限公司 |
磷苯妥英钠固体组合物、冻干方法、及其用途
|
|
WO2023225113A1
(en)
*
|
2022-05-18 |
2023-11-23 |
Bexson Biomedical, Inc. |
Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios
|
|
EP4705341A1
(en)
|
2023-05-05 |
2026-03-11 |
Euro-Celtique S.A. |
Combinations for treating cancer
|